NewsWorldWHO approves Pfizer-Biontech vaccine for emergency use

WHO approves Pfizer-Biontech vaccine for emergency use

 

The World Health Organization has granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution.

The decision “makes the vaccine the first to receive emergency validation from WHO since thenovel coronavirus outbreak began a year ago,” WHO said in a statement.

Britain launched its inoculation drive with the US-German vaccine on December 8, with the United States, Canada and EU countries following suit.

“This is a very positive step towards ensuring global access to COVID-19 vaccines,” said Mariangela Simao, a top WHO official tasked with ensuring access to medicines.

She did emphasize however, the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere.

WHO said its emergency use listing opens the way for regulators in different countries to approve the import and distribution of the vaccine.

It said it also enables UNICEF, which plays a key logistical role in distributing anti-Covid vaccines, and the Pan-American Health Organization to procure the vaccine for countries that need it.

WHO convened its own experts and those from around the world to review the data on the Pfizer/BioNTech vaccine’s “safety, efficacy and quality,” weighing the benefits against the risks.

Top Stories

Taste